Royal London has launched its long-awaited life cover for people with Type 1 or Type 2 diabetes.
The policy has the flexibility to reduce premiums by up to 40% to reflect how well the customer is managing their diabetes by sharing their HbA1c test result on an annual basis. Premiums are guaranteed never to rise higher than the starting premium to give clients certainty they will be able to maintain their cover, the insurer said. The customer journey is underpinned by the Kalibre insurtech platform that uses an "innovative" risk assessment approach, supported by continuous underwriting. The platform "revolutionises" the process of buying life insurance for people living with T...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
